What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

This is a link

  • This is a bullet
  • This is a bullet
  • This is a bullet
  • This is a bullet
Read the Whitepaper
AT A GLANCE
Every pharma deal ever — and btw: I made this

Introduction

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the Thisisaninlinelinkthishisisaninlinelinkthishisisaninlinelinkthigkhaegrkahgsshisisaninlinelinkthis

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

  1. Lack of visibility and connection to relevant investors: Researchers struggle to connect and acquire funding from private investors
  2. Legal complexity of IP deals: Deals such as license agreements surrounding pre-patent and patent IP are complex and often need legal support.
  3. Difficulty of determining the value of early-stage biopharma assets: Both funders and researchers have trouble assessing the value of early-stage research.

NFTs have created an unprecedented revolution in the creative space, rethinking copyright, royalties and IP. We believe it will also be instrumental in solving the above-stated problems. In this article, we are going to focus on the first technical implementation of a biopharma IPNFT. It builds on many concepts other influential thinkers in the Web3 space have conjured in the past. For example, if you are interested in how general IP can be combined with NFTs have a look at Trent McConaghy 3 part series on building IP NFTs with ERC721.

“When examining the transactional market for biopharma IP, one aspect becomes immediately obvious: IP is not sold in a simple purchase agreement like houses, cars or other physical objects. Transactions involving biopharma IP always differentiate between the specific rights and relating terms of the purchase.”

Every pharma deal ever — and btw: I made this

This is another header

This is just another paragraph

Latest proposals
Project
Gitcoin Longevity Donation Round
View Proposal
Passed
Governance 
VDP-12 Governance Framework Amendment #1
View Proposal
Passed
Funding
VDP-12 Governance Framework Amendment #1
View Proposal
Passed

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

  • This is a bullet
  • This is a bullet
  • This is a bullet
Join us, contribute ideas and keep up to date

VitaDAO Governance

Our venture development process

1
Application

Apply for funding from VitaDAO. Either with research that might create intellectual property or with a longevity startup. Read our FAQs below to find out what types of projects qualify.

Submit your project
2
Evaluation

Our scientific evaluation board will evaluate your application and come up with a suggestion for or against funding. Evaluation is independent of the final decision for funding.

Join the community
3
Voting & Funding

Qualified projects move to an on-chain funding proposal. VitaDAO members take the evaluation of our scientific board into consideration and vote for, or against funding the project.

Launch the DAO
LATEST NEWS & INSIGHTS
Longevity Research Newsletter June 2022
June 13, 2022
Longevity
Awareness
VitaDAO Newsletter Issue No 6 June 2022
June 3, 2022
Awareness
How Crypto Can Help Science & Medicine
April 23, 2022
Awareness
Upcoming Events
VitaDAO @ Longevity Med Summit - Lisbon, Portugal
Lisbon, Portugal
May 4-5, 2023
Learn More
1
The DAO opportunity

DAOs (Decentralized Autonomous Organisations) are digital structures, that make it possible for like minded people to safely collaborate and coordinate on a global scale. They are collectively owned and managed by their members. Decisions are governed by members writing proposals and voting to ensure everyone in the organisation has a voice.

Next: Longevity Science Today
2
Longevity science today

Our increased understanding of the underlying cause of all major age-related diseases is driving progress in the development of new therapies to prevent or reverse age-related diseases like cancer or alzheimers. We are funding research targeting the root causes of age-related diseases to increase human health and quality of life.

Next: Longevity Science Today
3
The VitaDAO strategy

VitaDAO is building a global community of longevity scientists and enthusiasts discovering and funding the most promising research. We are financing, researching and collectively supporting promising areas of longevity research.

Next: Longevity Science Today
1
The DAO opportunity

DAOs (Decentralized Autonomous Organisations) are digital structures, that make it possible for like minded people to safely collaborate and coordinate on a global scale. They are collectively owned and managed by their members. Decisions are governed by members writing proposals and voting to ensure everyone in the organisation has a voice.

Next: Longevity Science Today
2
Longevity science today

Our increased understanding of the underlying cause of all major age-related diseases is driving progress in the development of new therapies to prevent or reverse age-related diseases like cancer or alzheimers. 
We are funding research targeting the root causes of age-related diseases to increase human health and quality of life.

Next: The VitaDAO strategy
3
The VitaDAO strategy

VitaDAO is building a global community of longevity scientists and enthusiasts discovering and funding the most promising research. We are financing, researching and collectively supporting promising areas of longevity research.

Next: The DAO Opportunity
The Longevity Prize

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla.

This is some text inside of a div block.
This is some text inside of a div block.
VitaDAO Fellowship: Apply now!

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra orna.

This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

This is some text inside of a div block.
This is some text inside of a div block.
VitaDAO Fellowship: Apply now!

Funding promising individuals who are entering longevity with micro-grants. Enabled by co-donors from our Gitcoin project 'Longevity Fellowship Grants'.

The Longevity Prize

The Longevity Prize is awarding outstanding progress in longevity research — crowdsourced and curated by leading industry experts.

Longevity Quadratic Donation Round with Gitcoin

The VitaDAO community helped Gitcoin to curate and fund projects that further the mission and goals of Longevity science.

Repair Biotechnologies

Repair Biotechnologies is a preclinical-stage biotech company developing a first-in-class universal cell therapy for atherosclerosis. It aims to reduce the risk of cardiovascular events, such as heart attack and stroke.

$ 50,000
raised
Button Text

Cellular ‘Soap’ For Infectious Disease Accelerated Aging

Prevention of communicable disease via hygiene, antibiotics, vaccines and other innovations has provided the largest life expectancy gains in human history. It is increasingly appreciated that pathogens can age humans by driving cell senescence. Dr. Peterson has identified chemistry that acts as a cellular ‘soap’ to concomitantly thwart pathogens and senescent cells.

$ 231,000
raised
Button Text

Hyperspectral Imaging for AD

Mantis Photonics AB is developing a hyperspectral camera for retinal imaging for the early screening of Alzheimer Disease via the detection of the Amyloid beta peptide. The retina displays similarities to the brain and spinal cord in terms of anatomy, functionality and response to insult, hence, the eye providing a unique window to the central nervous system.

30,000 EUR
raised
Button Text

Support of Clinical Trial - The Effect of Regular Exercise & Intermittent Rapamycin Dosing

This clinical trial aims to investigate whether periods of time where the mechanistic target of Rapamycin (mTOR) pathway is activated via exercise, combined with alternate periods of time where mTOR is inhibited using Sirolimus (Rapamycin), will result in greater muscle performance in older adults compared with just exercise alone.

$ 50,000
raised
Button Text

Probing DNA Quadruplexes in Age Related Proteostasis

This project explores the role of DNA Helicases (WRN and BLM) and DNA quadruplexes (G4) structures in healthy and unhealthy aging and probing both the wanted and unwanted G4 structures and their impact on proteostasis maintenance, which may create the opportunity for novel drug targets.

$ 50,000
raised
Button Text

ApoptoSENS - Senolytic CAR-NK Cells

Senescent cells accumulate with age and are associated with numerous diseases. Dr. Amit Sharma’s team have identified senescence-specific cell surface biomarkers which will act as targets for developing Chimeric Antigen Receptor Natural Killer (CAR-NK) cells aiming to precisely and safely eliminate senescent cells in vivo.

$ 253,000
raised
Button Text

Reversing periodontal disease using Geroscience: Jonathan An

The greatest underlying risk factor for periodontitis is age, and its association with other age-related diseases. Jonathan An’s lab proposes to test a series of compounds targeting inflammation in a mouse model of age-related periodontitis, with the goal of finding a geroscience-based treatment for this neglected disease that has a severe impact on human healthspan.

$192,925
raised
Button Text

Longevity Hackers Film Participation

A groundbreaking documentary examining the latest research and scientific breakthroughs in the field of longevity and healthy life extension. Featuring wide-ranging interviews from the researchers leading the charge to longevity critics, the film aims to educate and raise awareness, whilst providing a balanced analysis of this exciting and pioneering space.

100,000
raised
Button Text

Discovery of novel mitophagy activators for Alzheimer’s disease

Mitophagy - the mechanism to recycle mitochondria - becomes dysregulated with age and is thought to be a driver of Alzheimer’s and other age-related diseases. The Fang lab aims to use a combination of artificial intelligence and a wet-lab validation platform to identify new mitophagy-activating drug candidates.

$ 300,000
raised
Button Text

Rubedo.Life

Rubedo is building a platform for longevity medicines using “smart drugs” (prodrugs) that have the capacity to selectively be activated in target cells predicted to be pathogenic and the cause of age-related diseases.

$ 350,000
raised
Button Text

Korolchuk Lab

Korolchuck lab proposes a drug discovery programme with the aim of identifying novel bioactive autophagy inducers. Activation of autophagy is considered a promising therapeutic approach to combat ageing and age-related diseases.

$ 285,000
raised
Button Text

Turn Biotechnologies

Turn Bio develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. They are reprogramming the epigenome – a network of chemical compounds and proteins controlling cell functions to restore capabilities that are lost with age.

$ 1,000,000
raised
Button Text

Scheibye-Knudsen Lab

What if therapeutics to slow down the aging process and prevent age-related disease already existed? The Scheibye-Knudsen Lab will use advanced machine learning to crunch the data from 1.04 billion prescriptions to understand the impact of drugs on human lifespan.

$ 250,000
raised
Button Text